The molecular mechanisms fueling prostate cancer pathogenesis remain relatively unknown15–19; however, topoisomerase II alpha (TOP2A), a nuclear enzyme involved in chromosome condensation and chromatid separation, has been shown to be upregulated with increasing Gleason score and with hormone insensitivity in prostate carcinoma20. Here, TOP2A is linked to prostate carcinoma.